The University of Chicago Header Logo

Connection

Fuad Baroody to Injections, Subcutaneous

Back to Details
This is a "connection" page, showing publications Fuad Baroody has written about Injections, Subcutaneous.
Fuad Baroody
Connection Strength
0.055
Injections, Subcutaneous
  1. Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial. J Allergy Clin Immunol. 2023 01; 151(1):192-201.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.